Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Fatty Alcohols | 2 | 2019 | 24 | 0.95 | Why? |
| Catechols | 2 | 2019 | 43 | 0.95 | Why? |
| Epigenomics | 1 | 2015 | 139 | 0.56 | Why? |
| DNA Methylation | 1 | 2015 | 688 | 0.42 | Why? |
| Chickens | 1 | 2015 | 1010 | 0.40 | Why? |
| Epigenesis, Genetic | 1 | 2015 | 711 | 0.38 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 907 | 0.38 | Why? |
| Y-Box-Binding Protein 1 | 2 | 2017 | 3 | 0.36 | Why? |
| Transcription Factors | 3 | 2019 | 784 | 0.35 | Why? |
| Aging | 2 | 2019 | 3581 | 0.29 | Why? |
| Lipid Metabolism | 2 | 2019 | 572 | 0.26 | Why? |
| Cancer-Associated Fibroblasts | 2 | 2019 | 18 | 0.25 | Why? |
| Transcriptome | 1 | 2015 | 3466 | 0.24 | Why? |
| Paracrine Communication | 2 | 2019 | 73 | 0.23 | Why? |
| Rats, Sprague-Dawley | 3 | 2019 | 987 | 0.22 | Why? |
| Lung Neoplasms | 4 | 2019 | 3228 | 0.21 | Why? |
| Chemokine CCL7 | 1 | 2020 | 39 | 0.21 | Why? |
| Adenocarcinoma | 2 | 2018 | 651 | 0.21 | Why? |
| KCNQ Potassium Channels | 1 | 2018 | 1 | 0.20 | Why? |
| Phenylenediamines | 1 | 2018 | 19 | 0.19 | Why? |
| Paclitaxel | 1 | 2018 | 124 | 0.18 | Why? |
| Nanog Homeobox Protein | 1 | 2017 | 11 | 0.18 | Why? |
| Proto-Oncogene Proteins c-met | 1 | 2017 | 40 | 0.17 | Why? |
| Hypotension | 1 | 2021 | 392 | 0.17 | Why? |
| Leptin | 1 | 2019 | 141 | 0.17 | Why? |
| Neuralgia | 1 | 2018 | 99 | 0.17 | Why? |
| Noninvasive Ventilation | 2 | 2021 | 2329 | 0.17 | Why? |
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 1014 | 0.17 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.17 | Why? |
| Massage | 1 | 2017 | 53 | 0.16 | Why? |
| Repetitive Sequences, Nucleic Acid | 1 | 2015 | 28 | 0.16 | Why? |
| Pseudogenes | 1 | 2015 | 61 | 0.16 | Why? |
| Peripheral Nervous System Diseases | 1 | 2018 | 193 | 0.16 | Why? |
| Neoplastic Stem Cells | 1 | 2017 | 120 | 0.15 | Why? |
| Oxidation-Reduction | 1 | 2018 | 540 | 0.15 | Why? |
| Neuroprotective Agents | 1 | 2018 | 240 | 0.15 | Why? |
| Chemokine CXCL10 | 1 | 2020 | 565 | 0.15 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.15 | Why? |
| Cervical Vertebrae | 1 | 2017 | 151 | 0.15 | Why? |
| Spinal Fractures | 1 | 2017 | 124 | 0.15 | Why? |
| Base Composition | 1 | 2015 | 203 | 0.15 | Why? |
| Promoter Regions, Genetic | 2 | 2017 | 823 | 0.15 | Why? |
| Carbamates | 1 | 2018 | 485 | 0.14 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.14 | Why? |
| CpG Islands | 1 | 2015 | 230 | 0.14 | Why? |
| Nomograms | 1 | 2021 | 790 | 0.14 | Why? |
| Spondylitis, Ankylosing | 1 | 2017 | 231 | 0.14 | Why? |
| Cell Proliferation | 2 | 2019 | 1973 | 0.14 | Why? |
| Cholesterol | 1 | 2018 | 660 | 0.14 | Why? |
| Angiotensin II | 1 | 2020 | 601 | 0.13 | Why? |
| Molecular Sequence Annotation | 1 | 2015 | 478 | 0.13 | Why? |
| Genome | 1 | 2015 | 341 | 0.12 | Why? |
| Neoplasm Grading | 3 | 2019 | 400 | 0.12 | Why? |
| Trans-Activators | 3 | 2019 | 170 | 0.12 | Why? |
| Cell Line, Tumor | 5 | 2019 | 3608 | 0.12 | Why? |
| Muscle, Skeletal | 1 | 2019 | 915 | 0.11 | Why? |
| Mitochondria | 1 | 2018 | 857 | 0.11 | Why? |
| Neoplasm Invasiveness | 3 | 2019 | 582 | 0.11 | Why? |
| Critical Illness | 5 | 2021 | 17281 | 0.11 | Why? |
| Up-Regulation | 1 | 2019 | 2249 | 0.11 | Why? |
| Lung Injury | 1 | 2020 | 919 | 0.10 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 896 | 0.10 | Why? |
| Single-Cell Analysis | 1 | 2020 | 2450 | 0.10 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.09 | Why? |
| Genome-Wide Association Study | 1 | 2015 | 1648 | 0.09 | Why? |
| Biomarkers | 3 | 2020 | 23361 | 0.09 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.08 | Why? |
| Disaster Planning | 1 | 2020 | 1680 | 0.08 | Why? |
| Transcriptional Activation | 2 | 2017 | 196 | 0.08 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.07 | Why? |
| Cell Movement | 2 | 2019 | 695 | 0.07 | Why? |
| Gene Expression Profiling | 1 | 2015 | 3788 | 0.07 | Why? |
| Liver | 1 | 2018 | 4007 | 0.07 | Why? |
| Signal Transduction | 2 | 2019 | 7207 | 0.07 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3633 | 0.06 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.06 | Why? |
| Gene Expression Regulation | 1 | 2015 | 4020 | 0.06 | Why? |
| Animals | 5 | 2019 | 78931 | 0.06 | Why? |
| Evolution, Molecular | 1 | 2015 | 3691 | 0.06 | Why? |
| Neoplasm Staging | 2 | 2018 | 1999 | 0.05 | Why? |
| Computational Biology | 1 | 2015 | 4514 | 0.05 | Why? |
| Male | 15 | 2021 | 367725 | 0.05 | Why? |
| Receptors, Adiponectin | 1 | 2019 | 6 | 0.05 | Why? |
| Mitochondria, Muscle | 1 | 2019 | 8 | 0.05 | Why? |
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2019 | 28 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Oleic Acid | 1 | 2019 | 43 | 0.05 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Coculture Techniques | 1 | 2019 | 258 | 0.05 | Why? |
| AMP-Activated Protein Kinases | 1 | 2019 | 93 | 0.05 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.04 | Why? |
| Medical Records | 1 | 2021 | 513 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.04 | Why? |
| Adiponectin | 1 | 2019 | 123 | 0.04 | Why? |
| Tumor Microenvironment | 1 | 2019 | 264 | 0.04 | Why? |
| Heterografts | 1 | 2017 | 203 | 0.04 | Why? |
| Antineoplastic Agents, Phytogenic | 1 | 2018 | 183 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 347 | 0.04 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 372 | 0.04 | Why? |
| MAP Kinase Signaling System | 1 | 2019 | 360 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2020 | 6543 | 0.04 | Why? |
| Aged | 10 | 2021 | 215776 | 0.04 | Why? |
| Random Allocation | 1 | 2018 | 773 | 0.04 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.04 | Why? |
| Blood Chemical Analysis | 1 | 2020 | 541 | 0.04 | Why? |
| Chemoprevention | 1 | 2020 | 585 | 0.04 | Why? |
| Ventilator Weaning | 1 | 2020 | 536 | 0.04 | Why? |
| Carcinogenesis | 1 | 2017 | 236 | 0.04 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.04 | Why? |
| Organ Dysfunction Scores | 1 | 2020 | 1475 | 0.03 | Why? |
| Insulin Resistance | 1 | 2019 | 669 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| Shock | 1 | 2020 | 1868 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.03 | Why? |
| A549 Cells | 1 | 2019 | 2066 | 0.03 | Why? |
| Neurons | 1 | 2018 | 864 | 0.03 | Why? |
| Humans | 17 | 2021 | 930598 | 0.03 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.03 | Why? |
| Lung | 2 | 2020 | 31049 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.03 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.03 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.03 | Why? |
| Female | 9 | 2021 | 380317 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.03 | Why? |
| Methylprednisolone | 1 | 2020 | 2107 | 0.02 | Why? |
| China | 3 | 2021 | 50654 | 0.02 | Why? |
| Kidney Diseases | 1 | 2020 | 1434 | 0.02 | Why? |
| Respiratory Insufficiency | 2 | 2020 | 7301 | 0.02 | Why? |
| Radiography | 1 | 2017 | 1576 | 0.02 | Why? |
| Pain Management | 1 | 2017 | 854 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Fatal Outcome | 1 | 2017 | 3438 | 0.02 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2020 | 2093 | 0.02 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.02 | Why? |
| Forecasting | 1 | 2021 | 4492 | 0.02 | Why? |
| HEK293 Cells | 1 | 2019 | 8394 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Binding Sites | 1 | 2017 | 6201 | 0.02 | Why? |
| Medicine, Chinese Traditional | 1 | 2017 | 2255 | 0.02 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.02 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.02 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
| Breast Neoplasms | 1 | 2018 | 3633 | 0.01 | Why? |
| Drug Repositioning | 1 | 2018 | 5683 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.01 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
Li's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(158)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_